Gopal R Vijayaraghavan

Gopal R Vijayaraghavan is a Professor in the Department of Radiology at UMass Chan Medical School, specializing in Breast Imaging within the T.H. Chan School of Medicine. His academic career spans multiple institutions across different countries, reflecting a global perspective on medical education and practice.

His educational background includes:

• MPH in Healthcare Management from Harvard University School of Public Health
• MBBS in Medicine and Surgery from Jawaharlal Institute of Postgraduate Medical Education and Research, India
• MD in RadioTherapy/Diagnosis from Tata Institute of Social Sciences, India
• Fellowship in Abdominal Imaging at University of Massachusetts Medical School
• Fellowship in Women's Imaging at Beth Israel Deaconess Medical Center
• Residency training at Armed Forces Medical College and Tata Memorial Hospital

Dr. Vijayaraghavan's research focuses primarily on breast imaging, cancer detection, and diagnostic radiology techniques. His work examines the intersection of technological advances with clinical outcomes, particularly in breast cancer screening and diagnosis. He has made significant contributions to understanding mammography, ultrasound, and digital breast tomosynthesis in cancer detection, with particular attention to underserved populations. His recent work explores artificial intelligence applications in breast imaging and the impact of the COVID-19 pandemic on cancer diagnosis pathways.

His publications demonstrate consistent focus on improving timeliness and accuracy of breast cancer diagnosis through advanced imaging techniques, including evaluation of screening mammograms, wireless localization technology for surgical guidance, and imaging-biology correlations in breast cancers.

Dr. Vijayaraghavan's work has received recognition through significant citation counts, particularly his research on AI-based breast cancer detection (72 citations) and COVID-19 vaccination effects on diagnostic imaging (43 citations).

He maintains active collaborations with researchers including Vedantham, Srinivasan; Kandil, Dina; and others, bridging clinical practice, technological innovation, and healthcare policy to improve breast cancer outcomes.